News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
579,591 Results
Type
Article (19057)
Company Profile (166)
Press Release (560367)
Multimedia
Podcasts (79)
Webinars (13)
Section
Business (198379)
Career Advice (709)
Deals (30736)
Drug Delivery (86)
Drug Development (65638)
Employer Resources (55)
FDA (12398)
Job Trends (11097)
News (287852)
Policy (24144)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (816)
Accelerated approval (39)
ADA (26)
Adcomms (10)
Allergies (140)
Alliances (41817)
ALS (141)
Alzheimer's disease (1261)
Antibody-drug conjugate (ADC) (338)
Approvals (12996)
Artificial intelligence (495)
ASCO (219)
Autoimmune disease (241)
Automation (40)
Bankruptcy (319)
Best Places to Work (8371)
BIO (47)
BIOSECURE Act (10)
Biosimilars (184)
Biotechnology (103)
Bladder cancer (149)
Brain cancer (55)
Breast cancer (597)
Cancer (4397)
Cardiovascular disease (345)
Career advice (614)
Career pathing (14)
CAR-T (215)
CDC (8)
Celiac Disease (1)
Cell therapy (604)
Cervical cancer (41)
Clinical research (58736)
Collaboration (1677)
Commercialization (2)
Company closure (1)
Compensation (1417)
Complete response letters (60)
COVID-19 (1280)
CRISPR (81)
C-suite (1012)
Cystic fibrosis (123)
Data (6489)
Decentralized trials (1)
Denatured (23)
Depression (124)
Dermatology (66)
Diabetes (436)
Diagnostics (4791)
Digital health (43)
Diversity (3)
Diversity, equity & inclusion (16)
Drug discovery (256)
Drug pricing (126)
Drug shortages (15)
Duchenne muscular dystrophy (223)
Earnings (80696)
Editorial (26)
Employer branding (5)
Employer resources (51)
Events (99072)
Executive appointments (938)
FDA (15457)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (27)
Funding (1192)
Gene editing (161)
Generative AI (35)
Gene therapy (452)
GLP-1 (671)
Government (2012)
Grass and pollen (5)
Guidances (331)
Healthcare (11037)
Hematology (128)
HIV (55)
Huntington's disease (28)
IgA nephropathy (94)
Immunology and inflammation (166)
Immuno-oncology (74)
Indications (190)
Infectious disease (1510)
Inflammatory bowel disease (172)
Inflation Reduction Act (9)
Influenza (96)
Intellectual property (288)
Interviews (94)
IPO (13968)
IRA (33)
Job creations (3104)
Job search strategy (556)
JPM (29)
Kidney cancer (20)
Labor market (39)
Layoffs (252)
Leadership (11)
Legal (6588)
Liver cancer (54)
Longevity (21)
Lung cancer (616)
Lymphoma (335)
Machine learning (35)
Management (18)
Manufacturing (877)
Marketing (10)
MASH (162)
Medical affairs (1)
Medical device (9238)
Medtech (9369)
Mergers & acquisitions (17906)
Metabolic disorders (1054)
mRNA (104)
Multiple sclerosis (139)
NASH (15)
Neurodegenerative disease (292)
Neuropsychiatric disorders (68)
Neuroscience (2390)
Neurotech (1)
NextGen: Class of 2026 (3895)
Non-profit (1262)
Now hiring (23)
Obesity (426)
Opinion (158)
Ovarian cancer (173)
Pain (241)
Pancreatic cancer (220)
Parkinson's disease (271)
Partnered (20)
Patents (563)
Patient recruitment (567)
Peanut (39)
People (50570)
Pharmaceutical (45)
Pharmacy benefit managers (23)
Phase 1 (18119)
Phase 2 (25829)
Phase 3 (19154)
Pipeline (8024)
Policy (163)
Postmarket research (2127)
Preclinical (7522)
Press Release (49)
Prostate cancer (233)
Psychedelics (30)
Radiopharmaceuticals (266)
Rare diseases (831)
Real estate (4461)
Recruiting (21)
Regulatory (19606)
Reports (22)
Research institute (954)
Resumes & cover letters (95)
Rett syndrome (40)
RNA editing (12)
RSV (52)
Schizophrenia (144)
Series A (216)
Series B (152)
Service/supplier (4)
Sickle cell disease (97)
Special edition (11)
Spinal muscular atrophy (112)
Sponsored (15)
Startups (2781)
State (2)
Stomach cancer (8)
Supply chain (94)
Tariffs (71)
The Weekly (54)
Vaccines (502)
Venture capital (53)
Weight loss (227)
Women's health (96)
Worklife (4)
Date
Last 7 days (326)
Last 30 days (1367)
Last 365 days (23055)
2026 (13185)
2025 (23305)
2024 (27250)
2023 (31377)
2022 (40750)
2021 (43344)
2020 (39862)
2019 (29683)
2018 (22624)
2017 (24680)
2016 (23525)
2015 (29425)
2014 (25673)
2013 (22074)
2012 (24099)
2011 (24440)
2010 (23672)
Location
Africa (466)
Alabama (79)
Alaska (2)
Arizona (319)
Arkansas (13)
Asia (30094)
Australia (4135)
California (12210)
Canada (3348)
China (1002)
Colorado (491)
Connecticut (445)
Delaware (267)
Europe (54507)
Florida (1854)
Georgia (391)
Hawaii (2)
Idaho (49)
Illinois (833)
India (87)
Indiana (543)
Iowa (14)
Japan (541)
Kansas (115)
Kentucky (36)
Louisiana (28)
Maine (27)
Maryland (1315)
Massachusetts (8404)
Michigan (316)
Minnesota (581)
Mississippi (5)
Missouri (101)
Montana (27)
Nebraska (16)
Nevada (114)
New Hampshire (68)
New Jersey (3085)
New Mexico (18)
New York (3014)
North Carolina (1465)
North Dakota (4)
Northern California (6082)
Ohio (292)
Oklahoma (16)
Oregon (27)
Pennsylvania (2338)
Puerto Rico (26)
Rhode Island (36)
South America (733)
South Carolina (78)
South Dakota (1)
Southern California (5025)
Tennessee (139)
Texas (1948)
United States (41400)
Utah (370)
Vermont (1)
Virginia (256)
Washington D.C. (51)
Washington State (952)
West Virginia (2)
Wisconsin (100)
Wyoming (1)
579,591 Results for "metaphore pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Metaphore Biotechnologies Announces Formation of Scientific Advisory Board to Advance the Next Era of Antibody Medicines
July 14, 2026
·
3 min read
Press Releases
Metaphore Biotechnologies Expands Executive Leadership Team with Appointment of Anabella Villalobos as Chief Scientific Officer
September 10, 2025
·
2 min read
Business
Novo Inks $600M Deal With Metaphore to Develop Next-Gen Obesity Drugs
As competition with Eli Lilly heats up, Novo Nordisk has partnered with Flagship’s Metaphore Biotechnologies to take a biomimicry approach to GLP-1s.
May 9, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
June 28, 2026
·
5 min read
Business
Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management
Metaphore Biotechnologies, a Flagship-founded biotechnology company designing novel therapeutics by combining machine learning and molecular mimicry, joined Flagship Pioneering in announcing a research collaboration with Novo Nordisk to develop up to two next-generation therapeutics for obesity management.
May 9, 2024
·
6 min read
Press Releases
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
July 15, 2026
·
2 min read
Press Releases
Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies
November 20, 2024
·
5 min read
Artificial intelligence
Alnylam hops on AI train with up to $2B Inceptive partnership
Alnylam Pharmaceuticals will leverage Inceptive Nucleics’ generative machine learning models to accelerate the development of RNA interference therapies.
June 4, 2026
·
1 min read
·
Tristan Manalac
Genetown
Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
Flagship Pioneering, the bioplatform innovation company, announced the launch of Metaphore Biotechnologies, a company harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics.
May 16, 2023
·
5 min read
Press Releases
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
May 5, 2026
·
6 min read
1 of 57,960
Next
